JP2008546640A5 - - Google Patents

Download PDF

Info

Publication number
JP2008546640A5
JP2008546640A5 JP2008511051A JP2008511051A JP2008546640A5 JP 2008546640 A5 JP2008546640 A5 JP 2008546640A5 JP 2008511051 A JP2008511051 A JP 2008511051A JP 2008511051 A JP2008511051 A JP 2008511051A JP 2008546640 A5 JP2008546640 A5 JP 2008546640A5
Authority
JP
Japan
Prior art keywords
composition
meta arsenite
treatment
sodium
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008511051A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008546640A (ja
JP5026408B2 (ja
Filing date
Publication date
Priority claimed from EP05076071A external-priority patent/EP1721615A1/en
Application filed filed Critical
Publication of JP2008546640A publication Critical patent/JP2008546640A/ja
Publication of JP2008546640A5 publication Critical patent/JP2008546640A5/ja
Application granted granted Critical
Publication of JP5026408B2 publication Critical patent/JP5026408B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008511051A 2005-05-09 2006-05-09 泌尿生殖器癌及びその転移の治療を意図した、亜ヒ酸、そのナトリウム塩、及びその誘導体を含む製薬組成物 Expired - Fee Related JP5026408B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05076071.9 2005-05-09
EP05076071A EP1721615A1 (en) 2005-05-09 2005-05-09 Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
PCT/KR2006/001731 WO2006121280A1 (en) 2005-05-09 2006-05-09 Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis

Publications (3)

Publication Number Publication Date
JP2008546640A JP2008546640A (ja) 2008-12-25
JP2008546640A5 true JP2008546640A5 (https=) 2012-06-14
JP5026408B2 JP5026408B2 (ja) 2012-09-12

Family

ID=35197739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511051A Expired - Fee Related JP5026408B2 (ja) 2005-05-09 2006-05-09 泌尿生殖器癌及びその転移の治療を意図した、亜ヒ酸、そのナトリウム塩、及びその誘導体を含む製薬組成物

Country Status (23)

Country Link
US (2) US20090011047A1 (https=)
EP (5) EP1721615A1 (https=)
JP (1) JP5026408B2 (https=)
KR (3) KR20150085122A (https=)
CN (2) CN104758312A (https=)
AR (1) AR054448A1 (https=)
AU (1) AU2006244767B2 (https=)
BR (1) BRPI0608716A2 (https=)
CA (3) CA2926846C (https=)
CY (2) CY1113475T1 (https=)
DK (2) DK1885380T3 (https=)
ES (2) ES2754372T3 (https=)
HU (1) HUE046029T2 (https=)
IL (3) IL187220A (https=)
LT (1) LT3067068T (https=)
PL (2) PL1885380T3 (https=)
PT (1) PT1885380E (https=)
RU (1) RU2401662C2 (https=)
SG (5) SG10201405278SA (https=)
SI (2) SI1885380T1 (https=)
TW (5) TWI539957B (https=)
WO (1) WO2006121280A1 (https=)
ZA (1) ZA200710559B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8945505B2 (en) * 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US20090246291A1 (en) * 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
US20120045520A1 (en) * 2008-08-21 2012-02-23 Sang Bong Lee Pharmaceutical composition comprising arsenite for the treatment of malignancy
CA2772411C (en) * 2009-09-10 2017-08-22 Kominox, Inc. Cancer stem cell-targeted and drug resistant cancer therapy
EP2477635A4 (en) * 2009-09-18 2013-03-27 Kominox Inc METHODS OF TREATING CEREBRAL TUMORS
US8735171B2 (en) 2010-01-13 2014-05-27 Institut National De La Santé Et De La Recherche Médicale (Inserm) Promyelocytic leukemia protein as a redox sensor
CN103442705B (zh) * 2011-01-11 2015-11-25 巴塞尔大学 用于治疗癌症和免疫抑制的昔洛舍平与线粒体抑制剂的组合
US20120251628A1 (en) * 2011-03-30 2012-10-04 Young Joo Min Compositions and methods for treatment of cancer
KR101309844B1 (ko) * 2013-03-15 2013-09-23 박상채 항암 활성 증진용 한약재 및 이의 제조방법
RU2618405C1 (ru) * 2015-12-31 2017-05-03 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ определения продолжительности адъювантной химиотерапии при местно-распространенном колоректальном раке с метастазами в регионарные лимфоузлы после радикальных оперативных вмешательств
US10806768B2 (en) * 2016-05-26 2020-10-20 Stephen N. Pitcher Composition for promoting metallothionein production
CA3041357A1 (en) 2016-12-01 2018-06-07 Eupharma Pty Ltd Diarsenic tetraoxide compositions and their use in the treatment of cancers
BR112020016884A2 (pt) 2018-02-26 2020-12-15 R.P. Scherer Technologies, Llc Forma de dosagem farmacêutica para uma emulsão de simeticona e loperamida
KR102868121B1 (ko) * 2018-03-22 2025-10-14 코미팜 인터내셔널 오스트레일리아 피티와이 엘티디 메타 아비산염을 포함하는 약학 조성물 및 제조 방법
WO2019234112A1 (en) * 2018-06-05 2019-12-12 Katholieke Universiteit Leuven Combination treatment of arsenic oxide and antiandrogens
MX2022010066A (es) * 2020-02-16 2022-08-25 Komipharm Int Australia Pty Ltd Metodo para tratamiento usando meta-arsenito.
KR20220020635A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 외용제 조성물
KR20220020637A (ko) * 2020-08-12 2022-02-21 이상봉 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물
KR20220020633A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 주사제 조성물
CN112336746A (zh) * 2020-10-23 2021-02-09 内蒙古科技大学包头医学院 一种膀胱癌灌注化疗药物及其应用
CN116549741B (zh) * 2022-01-29 2025-04-11 中国科学院上海硅酸盐研究所 一种具有抑癌抗菌作用的表面改性镍钛合金材料及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
FR2431686A1 (fr) 1978-07-20 1980-02-15 Nestle Sa Soc Ass Tech Prod Mecanisme de dosage et d'equilibrage et machine de remplissage comprenant un tel mecanisme
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
KR930001917A (ko) * 1991-07-26 1993-02-22 김두석 악성 종양 치료제의 제조방법
RU2035181C1 (ru) * 1994-02-18 1995-05-20 Тамара Васильевна Воробьева Средство для лечения лейкозов и способ лечения лейкозов
EP0804928B1 (en) * 1994-02-18 2004-10-20 Tamara Vasilievna Vorobieva Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system
US6875451B2 (en) * 1997-10-15 2005-04-05 Polarx Biopharmaceuticals Inc. Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
TR200002243T2 (tr) 1997-11-10 2000-12-21 Memorial Sloan-Kettering Cancer Center Arsenik trioksitin hazırlanması için işlem ve bunların kanser tedavisi için kullanımı.
CN1233476A (zh) * 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
KR20020083678A (ko) * 2001-04-28 2002-11-04 주식회사 한국미생물연구소 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
TW200408407A (en) 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
WO2003086424A1 (en) * 2002-04-10 2003-10-23 Korea Microbiological Laboratories, Ltd. Pharmaceutical composition comprising arsenite for the treatment of malignancy
KR100632250B1 (ko) * 2004-02-16 2006-10-11 정태호 비소 화합물을 유효성분으로 하는 항암제
US20060104292A1 (en) 2004-11-15 2006-05-18 Gupta Vivek G System and methods for supporting multiple communications interfaces with single client interface
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8945505B2 (en) 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US20090246291A1 (en) * 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
CA2772411C (en) 2009-09-10 2017-08-22 Kominox, Inc. Cancer stem cell-targeted and drug resistant cancer therapy

Similar Documents

Publication Publication Date Title
JP2008546640A5 (https=)
Dueñas-González et al. Epigenetics of cervical cancer. An overview and therapeutic perspectives
Roviello et al. Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments
JP2020519672A5 (https=)
HRP20200383T1 (hr) Ciljana vezna sredstva protiv b7-h1
JP2025512780A5 (https=)
Fu et al. Cell cycle arrest and induction of apoptosis by cajanin stilbene acid from Cajanus cajan in breast cancer cells
Politi et al. Epithelial-myoepithelial carcinoma of the parotid gland: Clinicopathological aspect, diagnosis and surgical consideration
JP2021520349A5 (https=)
JP2013544892A5 (https=)
Akgun et al. Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus
RU2015156221A (ru) Фармацевтические комбинация ингибитора pi3k и средства, дестабилизирующего микротрубочки
JP2013537228A5 (https=)
Shong-San et al. Adenoid cystic carcinoma of prostate report of a case
JP2018500355A5 (https=)
CA2656005A1 (en) Chemotherapeutic compounds for selectively targeting tumor cells with fr type receptors
Barua et al. Correlation of epidermal growth factor receptor score with prognostic variables in transitional cell carcinoma of urinary bladder among northeastern Indian population
JP2005513000A5 (https=)
Costa-Pereira et al. Molecular and cellular biology of prostate cancer—the role of apoptosis as a target for therapy
Fan Feline mammary tumors: current and future therapies.
Matsika et al. Epithelioid haemangioendothelioma of the uterine cervix with CAMTA1/WWTR1 translocation
Mabille et al. CT in the follow-up of advanced gastro-intestinal stromal tumors (GIST) under treatment by Imatinib Mesylate (Gleevec®): New criteria of evaluation
Dahabreh et al. Surgical resection of esthesioneuroblastoma metastasis to the chest wall
Park et al. Metastatic gastric adenocarcinoma presenting as a solitary plaque on the palm
Leung et al. Ductal type signet ring cell carcinoma of breast with growth pattern of pure mucinous carcinoma